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1. INTRODUCTION 
1.1. MITOCHONDRIA 
Mitochondria (derived from the Greek words mitos for thread and khondrion for small 
grain) are 0,5 – 1 µm big organelles that are present in most eukaryotic cells [1]. They 
are derived from eubacterial ancestors [2] and are composed of an outer membrane 
(OM), an inner membrane (IM) with invaginations called cristae and the matrix [3]. 
In the cell, mitochondria fulfill a variety of important functions: ATP generation 
through respiration for energy supply [2], calcium signaling, oxidation of fatty acids, 
lipid biosynthesis, haem biogenesis, cellular homeostasis, mitochondrial DNA 
maintenance and stress-induced and developmental apoptosis [3,4].  
Mitochondria are not static; they migrate within cells via microtubules and undergo 
continuous cycles of fission and fusion thereby forming a network-like structure. This 
process is called mitochondrial dynamics and enables cells to adapt to changing 
energy demands.  
 
 
 
Figure 1. Possible relationship between mitochondrial fusion, fission, biogenesis and degradation; 
adapted from Seo et al, 2010 [5]. 
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Fission and fusion ensure that mitochondria are well distributed, both inside cells (in 
distal parts and especially at sites where ATP is required) and during cell division [2, 
4, 6]. Moreover, fission causes degradation of defective sections and dysfunctional or 
misfolded proteins [7]. These very important processes, fission and fusion, are 
mediated by large, highly-conserved GTPases that belong to the dynamin 
superfamily. 
 
1.2. DYNAMIN-LIKE PROTEINS AND THEIR ROLE IN MITOCHONDRIAL 
DYNAMICS 
1.2.1. THE FUSION MACHINERY  
A. INNER MEMBRANE FUSION 
Human OPA1 (optic atrophy 1) and its yeast ortholog Mgm1 mediate fusion of the IM 
and cristae organization [4]. Both proteins are targeted to mitochondria by a 
mitochondrial targeting sequence (MTS) and are anchored to the IM with one 
transmembrane helix so that the GTPase domain points into the intermembrane 
space. The MTS is cleaved afterwards, producing the so-called L-form which is 
further processed into the S-form [4, 8]. In fact, various different isoforms are known 
that are formed by alternative splicing and proteolysis [3]. Regulation of IM fusion 
also involves a protein family called prohibitins [4]. 
 
B. OUTER MEMBRANE FUSION  
Human mitofusins (Mfn1 and Mfn2) and yeast ortholog Fzo1 are located at the OM 
and mediate its fusion. Both mitofusin proteins can form homo- or heterocomplexes 
which tether the membranes via an interaction of their coiled-coil domains together 
[3, 8]. 
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Mfn1 shows a higher GTPase activity than Mfn2 and is believed to mediate initial 
steps of the fusion process. Mfn2, however, shows a higher affinity for GTP and 
might be involved in regulation of the fusion complex assembly [2]. 
In 2006, mitofusin binding protein (MIB) was identified as a negative regulator: The 
55 kDa protein blocks GTPase activity of Mfns by binding to their GTPase domain via 
its co-enzyme binding domain [3, 4]. Other regulatory proteins are Bax and Bak, two 
pro-apoptotic members of the Bcl-2 (B cell lymphoma-2) family. In healthy cells, 
these proteins stimulate fusion, whereas in cells that undergo apoptosis, activation of 
Bax and Bak leads to inhibition of fusion [3]. Up to now, it is not clear whether the 
fusion processes of the inner and the outer membrane are coupled or independently 
executed [3]. 
 
1.2.2. THE FISSION MACHINERY 
A. IN YEAST: DNM1, FIS1 AND MDV1 
In yeast, mitochondrial fission is catalyzed by Dnm1 (dynamin-like protein 1), which is 
localized in the cytosol and upon self-assembly on the mitochondrial OM. 
Fis1, an 18 kDa protein, that is distributed throughout the OM of mitochondria, is 
believed to function as a membrane receptor which recruits Dnm1 assemblies and 
adaptor proteins Mdv1 and Caf4 to the membrane [3]. These interactions might be 
mediated by the cytosolic part of Fis1, which is considered to serve as a platform for 
protein interactions. The 80 kDa protein Mdv1 colocalizes and interacts with Dnm1 at 
mitochondrial fission sites and possibly facilitates division through promoting Dnm1 
assembly. The function of Caf4, a non-essential adaptor protein, is unknown. 
Interestingly, fission does not occur at all sites of the OM that are associated with 
Mdv1/Dnm1 complexes. 
Since all proteins mentioned above are localized to the OM, it is believed that an 
independent inner membrane division machinery exists. Mdm33, an IM-protein, has 
been identified as a possible mediator [2, 4]. 
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B. IN HUMANS: DRP1  
The main mitochondrial division factor DRP1 exists as a tetramer in the cytosol; only 
3% are associated with mitochondria [1, 6, 7, 9]. Upon apoptotic stimuli and Ca2+ 
release, DRP1 is targeted to the OM of mitochondria where it forms mitochondrial 
foci [3]. Interestingly, not at all foci fission occurs [4]. 
The mechanism of DRP1 translocation to the mitochondrial OM is still unclear and up 
to now, orthologs of the yeast Mdv1 or Caf4 have not been identified in higher 
eukaryotes [2]. 
So far it is believed that hFis, an integral OM protein, targets DRP1 through 
interaction with a yet unknown adaptor protein [4]. hFis is localized throughout the 
OM of mitochondria, predominantly in ganglioside rich microdomains [3]. Recent 
studies have shown that knockdown of hFis does not interfere with DRP1 
localization. Currently, an ortholog of the OM protein Mff (mitochondrial fission factor 
in Drosophila), which is predominantly located at the OM, is assigned to regulate 
fission by acting as a DRP1 receptor. This theory further states that DRP1 self-
assembles on Mff-bound sites of mitochondria and that hFis acts as an adaptor 
protein [4, 10]. 
Studies of DRP1 mutants that cannot bind GTP (K38A) showed that GTP binding is 
necessary for DRP1 assembly and translocation to mitochondria [2,4]. 
Membrane constriction requires GTP hydrolysis that induces conformational changes 
that ultimately lead to mitochondrial division. 
In the absence of DRP1, fission of the IM occurs independently. So far, however, no 
Mdm33 ortholog has been found in higher eukaryotes [2]. 
One possible component of this inner membrane division machinery may be the IM-
protein MTP18 [2, 4]. 
 
 
 
 
 
 
 
 1.3. HUMAN DYNAMIN-
Dynamin-related protein 1 (UniProt number: O00429) is also termed dynamin
protein (DLP1) or human dynamin IV (HdynIV
self-assembling GTPase that mediates mitochondrial fission in humans.
So far, 6 isoforms of DRP1 are described in humans. In literature, isoform 1 (736 
amino acids) has been chosen as the `canonical`
a part of the flexible linker region and differ in their expression
The domain architecture comprises a large, amino
middle domain, a flexible linker 
terminal GTPase effector domain (GED). The middle domain and the GED are 
involved in oligomerization, which leads to enhanced GTPase activity
mutations in the middle domain, like 
and microcephaly, prevent formation of higher oligomers 
 
 
Figure 2. Domain architecture of DRP1.
 
Several studies have shown that an increase of DRP1 expression, which is 
predominantly located in the cytosol, does not alter the rate of fission. Post
translational modifications, however, can regulate protein translocation, assembly 
and GTPase activity [1]. 
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RELATED PROTEIN 1 - DRP1  
). The 82 kDa protein is a 736 residue, 
 sequence. The other isoforms lack 
 pattern.
-terminal GTPase domain, a 
region (also referred to as insert B [1]
A395D which was reported with neonatal death 
[11]. 
 
-like 
 
 
) and a carboxy-
 [7]. Therefore, 
 
-
 - INTRODUCTION - 
 
 - 6 -  
1.3.1. POST-TRANSLATIONAL MODIFICATIONS OF DRP1 
PHOSPHORYLATION 
Several serine residues of DRP1, namely S616, S637 and S656 can be 
phosphorylated by a number of protein kinases. This kind of modification has 
opposite effects: Whereas Benard et al stated that phoshporylation stimulates 
fission [3], other studies report inhibition of fission [1, 4, 8]. 
UBIQUITINATION 
Usually, polyubiquitination of a protein is a signal for degradation by the 
proteasome. In this case, it is believed to play a regulatory role in DRP1 assembly 
[3]. Whether ubiquitination exerts a stimulating or an inhibiting effect on DRP1-
mediated fission is not yet clear  [1, 4, 8]. 
SUMOYLATION 
SUMO (Small ubiquitin-like modifier), a modulator of protein activity, usually 
changes the localization of proteins inside the cell or protects against ubiqutin-
mediated degradation by binding lysine residues. Again, the effect on DRP1 is 
controversial [1, 3, 4, 8].  
 
1.4. THE DYNAMIN SUPERFAMILY  
The dynamin superfamily is a group of large, self-assembling GTPases that mediates 
fusion and fission of vesicles and organelles, cytokinesis, pathogen resistance and 
the formation of the cell plate and the division of chloroplasts in plants [2, 6, 12]. All 
members of the family are highly conserved across species. Characteristic features 
include the large GTPase domain, the ability to self-assemble into higher oligomers 
that form ring- and helix-like structures and the assembly-stimulated GTPase activity. 
 
In contrast to members of the small GTPase family (like ras-like GTPases, α subunits 
of the hetero-trimeric G-proteins and GTPases involved in protein synthesis), the 
large GTPase domain of the dynamin superfamily comprises approximately 300 
amino acids [6, 13].  
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Whereas ras-like GTPases need other proteins, the GAPs (GTPase-activating 
proteins) for GTPase activity, and the GEFs (guanine exchange factors) for exchange 
of the nucleotide, members of the dynamin superfamily mediate GTPase activation 
by self-assembly. Due to their relatively low affinity to guanine nucleotides, the fast 
turn-over rate and the fast dissociation rate of GDP, proteins of the dynamin 
superfamily do not require nucleotide exchange factors [2, 6, 13]. 
 
The GTPase domain contains four GTP-binding motifs, named G1 - G4 (Figure 3.). 
Each GTPase binds one molecule of GTP:  
The G1 motif (consensus sequence: GxxxxGKS) is located in the P-loop and 
coordinates the γ-phosphate, a conserved threonine residue in G2 is involved in 
catalysis, the glycine residue in G3 (consensus sequence: DxxG) forms a hydrogen 
bond with the γ-phosphate of GTP and G4 (consensus sequence: NKxD) coordinates 
the base and the sugar [6].  
 
     G1   G2  G3  G4 
 
 
 
 
 
 
 
 
 
Figure 3. GTP-binding motifs G1 – G4; adapted from Praefcke et al, 2004 (6). Identical amino acid 
residues are shown in red. DLP1 – dynamin-like protein 1, OPA1 – optic atrophy 1, GBP1 – guanylate-
binding protein1. 
 
Apart from the GTPase domain, the domain architecture of all members comprises a 
middle domain and a GTPase effector domain (GED): 
The middle domain has been shown to interact with the GED and plays an important 
role in oligomerization [7, 11, 12, 14, 15]. 
 
IAVVGGQSAGKSSVLENFVG SGIVTRRPLV LVDLPGMTKV VITKLDL 
IVVVGTQSSGKSSVLESLVG TGIVTRRPLI LVDLPGMTKV VITKLDL 
IAVIGDQSSGKSSVLEALSG SGIVTRCPLV LIDLPGITRV ILTKPDL 
VVVVGDQSAGKTSVLEMIAQ GEMMTRSPVK LVDLPGVINT VLTKVDL 
VAFFGRTSSGKSSVINAMLW IGHITNCFLS LVDSPGTDVT LNNRWDA 
VAIVGLYRTGKSYLMNKLAG VQSHTKGIWM LLDTEGLGDV VWTLRDF 
VSVAGAFRKGKSFLMDFMLR NEPLTGFSWR LMDTQGTFDS IFLVRDW 
VAVTGETGSGKSSFINTLRG GAAKTGVVEV FWDLPGIGST VRTKVDS 
LVVVGAGGVGKSALTIQLIQ EYDPTIEDSY ILDTAGQEEY VGNKCDL 
IVVIGHVDSGKSTTTGHLIY ERGITIDISL IIDAPGHRDF GVNKMDS 
 
    GxxxxGKS      T         DxxG    NKxD    T        T 
 
Dynamin1 
DLP1 
MxA 
OPA1 
Mitofusin 
GBP1 
Atlastin1 
IIGP1 
p21 Ras 
EF1α 
 
Consensus 
 
 
The backfolding of the GED 
assembly and assembly-stimulated GTPase activity
The pleckstrin-homology (PH
not present in all dynamin family mem
phospholipid membranes. 
homology-3) domains of proteins
The dynamin superfamily can be divided into the dynamins, the dynamin
(including DRP1, Mx-proteins, OPA
proteins (guanylate-binding proteins) and the Vps1
sorting) [6, 17]. 
 
1.4.1. DYNAMINS  
The founding member dynamin 1
catalyzes the fission of clathrin
Moreover, dynamins are involved in budding of caveolae, in phagocytosis and in 
cytokinesis [6]. The domain architecture (
GTPase domain, a middle domain, 
So far, 5 isoforms are known in humans
tetramer within cells [12, 19]. 
 
 
Figure 4. Domain architecture of human dynamin 1. 
effector domain, PRD – proline rich domain.
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onto the GTPase-middle domain is also involved in self
 [9, 16].  
) domain, as well as the proline-rich domain (PRD) are
bers. The PH domain mediates binding on 
The PRD is responsible for interaction with 
 [6, 16]. 
1, mitofusin 1 and mitofusin 2), the GBP
-like proteins (vacuolar protein 
 (UniProt number: Q05193), an 100 kDa protein, 
-coated pits from the plasma membrane [16, 18].
Figure 4) comprises an amino
a PH domain, a GED and a PRD
. Dynamin has been shown to exist as a 
 
PH – pleckstrin homology, GED 
 
-
 
SH3 (Src-
-like proteins 
-related 
 
-terminal 
 [16, 18]. 
 
– GTPase 
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1.4.2. DYNAMIN-LIKE PROTEINS  
All dynamin-like proteins (Dlp´s) lack the PRD. They fulfill a variety of important 
functions in cells [6]. 
Human OPA1 (optic atrophy 1) and Mgm1 (mitochondrial genome maintenance 1) 
from S. cerevisiae mediate fusion of the inner membrane of mitochondria. They 
contain a mitochondrial targeting -  and a transmembrane sequence. 
Fusion of the outer mitochondrial membrane involves Mfn´s (mitofusins) in humans 
and Fzo1 (fuzzy onions 1) in yeast [6, 20]. 
Mitochondrial fission is catalyzed by DRP1 (dynamin-related protein 1) and Dnm1 
(dynamin-like protein 1) in humans and yeast, respectively.  
Mx-like proteins (human MxA and MxB) are expressed upon type I interferon 
production and protect against viruses. GBPs/atlastins mediate protection against 
intracellular pathogens. 
 
1.5. THE STRUCTURE OF DYNAMIN AND OTHER MEMBERS OF THE 
DYNAMIN SUPERFAMILY 
In 2001, the structure of nucleotide-free and GDP-bound form of the GTPase domain 
of dynamin A from Dictyostelium discoideum was solved (PDB ID 1JWY and 1JX2) 
[21] and in 2005, Reubold et al managed to solve the crystal structure of the rat 
dynamin GTPase domain (PDB ID 2AKA) [22]. In the last few years, the structures of 
several members of the dynamin superfamily, like the stalk of MxA (PDB ID 3LJB) 
[23], the bacterial dynamin-like protein (PDB ID 2J68) [24] and the guanylate-binding 
protein1 (PDB ID 1DG3) [25], have been solved.  
 
In 2010, Chappie et al crystallized a part of human dynamin 1 (monomeric GTPase 
domain-GED fusion protein, PDB ID 2X2E) [16]. By adding GDP, sodium flouride and 
aluminium chloride, a dimeric transition state mimic was formed. 
Chappie et al proposed a model for dynamin assembly, which explains the enhanced 
GTPase activity of dynamin upon oligomerization:  
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In full length dynamin, the C-terminal part of the GED interacts with the GTPase 
domain in trans to form a dimer. Further on, two dimers assemble via their stalk to 
form a tetramer. Between tetramers, G domain dimerization leads to formation of  
higher oligomers [16, 26]. 
Dimerization of the GTPase domains induces a conformational change in the active 
site that brings the different parts of the catalytic machinery together and leads to 
assembly-stimulated GTPase activity [16]. As a result, the catalytic water molecule, 
that mediates a nucleophilic attack on the γ-phosphate of GTP, is positioned at the 
correct site. The developing negative charge is compensated by a sodium ion and a 
magnesium ion and flexible switch regions are stabilized. 
Recently, the crystal structures of rat dynamin 1 [27] and human dynamin 1 [18], both 
lacking the PRD, have been solved. 
 
1.5.1. CRYSTAL STRUCTURE OF HUMAN DYNAMIN 
The GTPase domain of human dynamin consists of a curved beta-sheet of six 
strands, surrounded by five α-helices [6, 18]. The BSE (bundle signaling element) is 
built up of three α-helices from the amino-terminal GTPase domain, the carboxy-
terminal GTPase domain and the carboxy-terminal part of the GED. 
The bundle signaling element is connected to the stalk – a bundle of four anti-parallel 
helices formed by the middle domain and the amino-terminal GED [18, 27]. 
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Figure 5. Structure of nucleotide free human dynamin 1, adapted from Faelber et al [18]. 
 
In 2011, Faelber et al managed to solve the crystal structure of human, nucleotide-
free dynamin that lacks the PRD (PDB ID 3SNH) [18]:  
Oligomerization is mediated through assembly of the stalks of neighbouring 
molecules, which are arranged in a criss-cross fashion, building a linear filament. 
Within the stalk, three conserved interfaces are involved in the assembly of higher 
order structures.  
Upon GTP binding, rearrangements in the stalk induce a bent. In the helix, the 
GTPase domains of neighbouring molecules come together and GTPase activity is 
enhanced [18]. 
 
 
 
 
 
 
 
 
GTPase domain 
BSE 
Stalk 
PH domain 
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1.5.2. CRYSTAL STRUCTURE OF RAT DYNAMIN 
Also in 2011, Ford et al solved the crystal structure of nucleotide-free rat dynamin 1 
lacking the PRD (PDB ID 3ZVR) [27]. Like in human dynamin, a linear filament is built 
up by dimers that assemble via three interfaces in the stalk. Upon GTP binding and 
assembly, helix formation – the linear filament gets positioned into rings – is mediated 
by a GTPase-GTPase interface. Furthermore, Ford et al states that the PH domain 
might link the dynamin assembly to membrane interactions by regulating access to 
one of these interfaces that shifts during helix formation [27]. 
 
Most recently, the crystal structure of the GTPase domain and the GED of dynamin-
related protein 1 A from A. thaliana was solved by Chen et al [28]. 
 
1.6. DYNAMIN-LIKE PROTEINS AND THEIR ROLE IN DISEASE  
The process and proper function of mitochondrial dynamics is particularly important 
in cells of the nervous system, amongst others due to their high energy demand. 
Thus, defects in mitochondrial fission or fusion lead to various neurodegenerative 
disorders [4, 8]:  
Mutations in the gene encoding mitofusin 2 cause Charcot-Marie-Tooth neuropathy. 
OPA1 mutations are associated with dominant optic atrophy type 1 (DOA) [3]. 
A mutation in the middle domain of DRP1, namely A395D – a highly conserved 
residue, has been reported to cause microcephaly and abnormal brain development 
which leads to neonatal death. This mutation inhibits higher order assembly and 
probably translocation of DRP1 to the OM. Consistently, a decrease in GTPase 
activity was reported, which in turn leads to elongated mitochondria [11]. 
Alzheimer´s disease (AD) and Parkinson´s disease (PD) are associated with 
mitochondrial dysfunction that results in inhibition of the respiratory system and 
oxidative damage due to an increased production of reactive oxygen species (ROS) 
[8, 29]. 
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In Huntington´s disease, the gene encoding huntingtin (Htt) is mutated. The function 
of wildtype Htt within cells is not known. The insertion of multiple CAG repeats leads 
to the attachment of polyglutamine to the N-terminus of the protein [29]. The number 
of glutamine residues (6 - 35 in the wildtype protein) has been shown to correlate 
with the severity of the disease. Recently, Song et al showed that mutant huntingtin – 
in comparison to the wildtype protein - exhibits a stronger interaction with DRP1, 
thereby increasing its activity. This leads to fragmentation of cristae and 
mitochondria. Later on, Htt aggregation and neuronal cell death is observed. Thus, 
DRP1 might be a new drug target in treatment of Huntington´s disease [30] and 
therefore, its crystal structure is of great interest and high clinical relevance. 
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2. MATERIAL AND METHODS 
 
2.1. CONSTRUCTS  
Constructs listed below have been optimized for crystallizing full length or at least 
parts of DRP1 and DNM1. Different experimental approaches include the removal of 
variable regions and introduction of mutations that inhibit higher order assembly, 
since both might impede crystallization. 
 
2.1.1. DNM1 (YEAST) 
DNM1 (Dynamin-related protein 1) was a gift from the laboratory of Jodi Nunnari. 
 
DNM1 constructs   
 Construct 
name 
Construct 
design 
Aa MW 
(kDa) 
Vector His (6)-tag 
Wildtype E 59* 
E 60* 
M1 – L765 
M1 - L 782 
765 aa 
782 aa 
86  
88,1 
pHIS-P2 
pET-21 
N-term.  
C-term.  
 
G385D  
Mutation 
full length 
E 61 
E 62* 
M1 - L765 
M1 - L782 
765 aa 
782 aa 
86,1  
88,2  
 
pHIS-P2 
pET-21 
N-term.  
C-term.  
 
Table 1. List of  DNM1 constructs E 59, E 60, E 61 and E 62 with corresponding number of amino 
acids (aa) and molecular weight. Constructs labeled with a star were cloned by Mag. Klinglmayr.  
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2.1.2. DRP1 (HUMAN) 
DRP1 (Dynamin-related protein 1, Isoform 1) was a gift from the laboratory of Ella 
Bossy-Wetzel.  
 
DRP1 constructs 
 Construct 
name 
Construct 
design 
Aa MW  
(kDa) 
Vector His (6)-
tag 
GTPase 
domain- 
GED 
fusion 
constructs 
E 63* 
E 64 
M1-D328 fused with K711- W736  
M1-D328 fused with K711- W736  
369 
386 
40,9  
43  
pET-21 
pHIS-P2 
C-term.  
N-term.  
E 65 
E 66* 
M1-D328 fused with K635- W736 
M1-D328 fused with K635- W736 
437 
454 
49,2  
51,3  
pET-21 
pHIS-P2 
C-term.  
N-term.  
Mutation 
constructs 
E 67 
E 68 
E 69 
M1- W 736: A395D 
M1- W 736: G350D 
M1- W 736: G363D 
736 
736 
736 
83 
83 
83 
pET-21 
pET-21 
pET-21 
C-term.  
C-term.  
C-term 
GTPase 
domain 
constructs 
E 70* 
E 71* 
E 72* 
M1 - S321 
M1 - G323 
M1 - D327 
348 
350 
354 
39,1 
39,4 
39,8  
pHIS-P2 
pHIS-P2 
pHIS-P2 
N-term.  
N-term.  
N-term.  
Table 2. List of DRP1 constructs E 63 – E 72 with corresponding number of amino acids (aa) and 
molecular weight. Constructs labeled with a star were cloned by Mag. Klinglmayr.  
Note: In the following, “GTPase domain-GED fusion protein” refers to the protein encoded by construct 
E 63. 
 
2.2. VECTORS 
2.2.1. PET-21 
The pET-21 vector was obtained from Novagen: It is 5450 bp long and encodes a C-
terminal His-tag under the control of a T7 promoter and Ampicillin for selection.  
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2.2.2. PHIS-PARALLEL 2 
The multiple cloning site of pHIS-Parallel 1 was modified in a way that cloning with 
NdeI and XhoI leads to the attachment of a N-terminal 6 x His tag, which can be 
cleaved by the rTEV protease. The modified vector pHIS-Parallel 2 used in this study 
is ~ 5500 bp long and encodes Ampicillin for selection.  
 
2.3. CLONING 
As already mentioned, cloning of DNM1 constructs E 59, E 60 and E 62 as well as 
DRP1 constructs E 63, E 66 and E 70 – E 72 was performed by Mag. Klinglmayr. 
DNM1 G385D mutation construct E 61 was subcloned into vector pHIS-P2 by 
performing PCR. The DNM1 G385D DNA sequence in another vector was used as a 
template. 
 
2.3.1. PCR 
PCR was performed using a Thermal Cycler (Eppendorf). Primer sequences are 
listed in the Appendix. 
 
 
Table 3. PCR  reaction setup for construct E 61.* iProof High-Fidelity Master Mix (Bio-Rad) contains 
reaction buffer, 0,04 u/µL iProof polymerase and 400 µM dNTPs. 
 
 
PCR reaction setup (E 61):  
DNM1 G385D DNA 0,2 µL 
2 x Mastermix* 12,5 µL 
DNM1 primer forward (100 µM) 0,25 µL 
DNM1 primer reverse (100 µM) 0,25 µL 
dd H2O 11,8 µL 
  25 µL 
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PCR program:  
→ Initial denaturation:  1   x 98°C 30´´ 
→ Denaturation:   30 x 98°C 10´´ 
→ Annealing:                  60°C 20´´ 
→ Extension:                  72°C 1´10´´  
→ Final extension:  1 x  72°C 7´ 
→ Cool down to:                      4°C. 
 
2.3.2. OVERLAP PCR 
Cloning of DRP1 constructs E 64, E 65, E 67 – E 69 was carried out by performing 
overlap PCR. Primer design was performed with PrimerX 
(http://www.bioinformatics.org/primerx/). Sequences are listed in the Appendix.  
 
PCR 1 – 5´part  PCR 1 – 3´part  
DRP1 fl DNA 0,2 µL  DRP1 fl DNA 0,2 µL 
2 x Mastermix* 12,5 µL  2 x Mastermix* 12,5 µL 
DRP1 primer forward 
(100 µM) 
0,25 µL  DRP1 primer reverse 
(100 µM) 
0,25 µL 
Fusion/Mutation primer 
reverse (100 µM) 
0,25 µL  Fusion/Mutation primer  
forward (100 µM) 
0,25 µL 
dd H2O 11,8 µL  dd H2O 11,8 µL 
  25 µL    25 µL 
Table 4. PCR 1 reaction setup.* iProof High-Fidelity Master Mix (Bio-Rad) contains reaction buffer, 
0,04 u/µL iProof polymerase and 400 µM dNTPs. 
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PCR program:  
→ Initial denaturation:  1   x 98°C 30´´ 
→ Denaturation:   30 x 98°C 10´´ 
→ Annealing:                  60°C 20´´ 
→ Extension:                 72°C 1´  
→ Final extension:            1 x   72°C 7´ 
→ Cool down to:                      4°C. 
 
PCR products were loaded onto a preparative 1% agarose gel. The gel slices with 
the bands were excised and centrifuged for 10 minutes at RT in a table top centrifuge 
(Biofuge pico, Heraeus). The supernatant was used as template for PCR 2: 
   
PCR 2 - elongation  
5´part of PCR1    1 µL 
3´part of PCR1    1 µL 
2 x Mastermix* 25 µL 
dd H2O 22 µL 
  49 µL 
Table 5. PCR 2 reaction setup. * iProof High-Fidelity Master Mix (Bio-Rad) contains reaction buffer, 
0,04 u/µL iProof polymerase and 400 µM dNTPs. 
 
PCR program:  
→ Initial denaturation:  1 x 98°C 30´´ 
→ Denaturation:   7 x 98°C 10´´ 
→ Annealing:              50°C 25´´ 
→ Extension:                    72°C 1´10´´  
→ Final extension:   1 x 72°C 7´  
→ Cool down to:                    4°C. 
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PCR 3 
0,5 µL of each DRP1 primer (100 µM) were added to the PCR product of PCR 2. 
 
PCR program:  
→ Initial denaturation:   1  x 98°C 30´´  
→ Denaturation:    35 x 98°C 10´´  
→ Annealing:                62°C 25´´  
→ Extension:                   72°C 1´30´´  
→ Final extension:   1  x 72°C 7´  
→ Cool down to:            4°C. 
 
Again, PCR products were loaded onto a preparative 1% agarose gel. The bands 
were excised and DNA was extracted using Wizard® SV Gel and PCR Clean-Up 
System (Promega). 
 
2.3.3. DIGESTION 
Digestion of PCR products and vectors was performed with 2 µL of Fast digest 
restriction enzymes NdeI and XhoI (Fermentas Life Sciences, 1u/µL) for 1 hour at 
37°C.  
 
Digestion  
DNA 24 µL 
NdeI (1u/µL) 2 µL 
XhoI (1u/µL) 2 µL 
10 x FastDigest buffer* 4  µL 
dd H2O 8  µL 
  40 µL 
Table 6. Reaction setup for digestion. *10 x FastDigest buffer was provided by Fermentas Life 
Sciences together with the restriction enzymes. 
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After digestion, heat inactivation of the restriction enzymes was performed at 80°C 
for 10 minutes. In order to prevent re-ligation of digested vector, dephosphorylation 
was carried out for 10 minutes at 37°C by using 2 µL FastAP Thermosensitive 
Alkaline Phosphatase (Fermentas Life Sciences, 1u/µL). Dephosphorylated vectors 
were loaded onto an agarose gel and gel slices were excised. Vectors and inserts 
were cleaned up using Wizard SV Gel and PCR Clean-Up System (Promega).  
 
2.3.4. LIGATION 
Ligation was performed at RT for at least 30 minutes using 0,5 µLT4 DNA ligase 
(Fermentas Life Sciences, 5 u/µL ). 
 
Ligation  
Ligase (5u/µL) 0,5 µL 
10 x T4 DNA ligase buffer * 1 µL 
Vector x  µL 
Insert x  µL 
dd H2O x µL 
 10 µL 
Table 7. Reaction setup for ligation. * T4 DNA Ligase buffer was provided by Fermentas Life Sciences 
together with the T4 DNA ligase and contains 400 mM Tris-HCl, 100 mM MgCl2, 100 mM DTT and 5 
mM ATP. 
 
The vector insert ratios were calculated as follows, the molar ratio of insert/vector 
used was 3:1. 
 
(ng vector) x (size of insert in kB) 
        (size of vector in kB)        x   molar ratio of (insert/vector) = ng insert 
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2.3.5. TRANSFORMATION 
After ligation, plasmids were transformed into chemically competent E.coli Top 10 
(Invitrogen) by heat shock:  
50 µL bacteria were thawed on ice. 5 µL plasmid were added. After tapping, samples 
were incubated on ice for 10 minutes, followed by an incubation at 42°C for 1 minute. 
To recover cells, 500 µL LB-medium (Luria Broth medium) were added and incubated 
for 45 minutes at 37°C while shaking. Bacteria were plated on LB Amp plates. 
 
2.3.6. COLONY PCR  
Colony PCR was performed by using 0,25 µL Dream Taq Green DNA Polymerase 
(Fermentas Life Sciences, 5 u/µL) to control the efficiency of transformation. Single 
colonies were picked and used as templates: 
 
Colony PCR  
Bacterial cells  
dNTP Mix° (0,2 mM)  0,65 µL 
T 7 primer forward (100 µM) 0,25 µL 
T7 primer reverse (100 µM) 0,25 µL 
10 x Dream Taq buffer* 2,5 µL 
Dream Taq Polymerase (5 u/µL)  0,25 µL 
dd H2O 21,1  µL 
  25 µL 
Table 8. Reaction setup for colony PCR. o 0,2 mM dNTP Mix  was supplied with Dream Taq 
Polymerase from Fermentas Life Sciences and used at a final concentration of 0,5 mM. *10 x  Dream 
Taq buffer was provided by Fermentas Life Sciences together with the Dream Taq Polymerase and 
contains KCl, (NH4)2 SO2 and  20 mM MgCl2. 
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PCR program: 
→ Initial denaturation:    1 x  95°C 3´  
→ Denaturation:  35 x 95°C 30´´  
→ Annealing:                    50°C 30´´  
→ Extension:                     72°C 2´30´´  
→ Final extension:    1  x 72°C 7´ 
→ Cool down to:             4°C. 
 
Plasmid preparations were performed using a GeneJET Plasmid Miniprep Kit 
(Fermentas Life Sciences) and sent to Eurofins MWG Operon for sequencing.  
 
2.3.7. AGAROSE GEL ELECTROPHORESIS  
Visualization of DNA was performed with Gel Red (Biotium Inc.). Gels were run at 
100 V for 40 minutes and visualization was carried out by Ultraviolet Transilluminator 
Gel Doc-It Imaging system (Biolmaging Systems). 
 
2.4. PROTEIN EXPRESSION 
Sequenced DNM1 and DRP1 constructs were transformed into chemically competent 
E. coli BL-21 DE 3 (Invitrogen) cells by heat shock: 50 µL bacteria were thawed on 
ice. 5 µL plasmid were added. After tapping, samples were incubated on ice for 10 
minutes, followed by an incubation at 42°C for 1 minute.To recover cells, 500 µL LB-
medium (Luria Broth medium) were added and incubated for 45 minutes at 37°C 
while shaking. Bacteria were plated on LB plates supplemented with Ampicillin (50 
µg/mL) and incubated at 37°C overnight.  
Colonies were resuspended from LB plates, transferred into 1 x 600 mL LB Amp 
medium (50 µg/mL Ampicillin) and grown for 4h at 37°C (250 rpm, Rocker 25, Labnet 
International Inc.) until OD600 ~ 0.8.  
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Protein expression was induced by addition of 0,45 mM IPTG and performed at 25°C 
overnight. Cells were harvested by centrifugation at 4500 rpm for 15 minutes (Sorvall 
RC 6. SLC-4000, Thermo Electron Corporation), pellets were resuspended in 1/20 
volume of Lysis buffer (see Appendix) and frozen at – 20°C overnight.  
For large scale expressions up to 12 flasks á 600 mL were combined. 
 
2.5. PROTEIN PURIFICATION 
2.5.1. CELL LYSIS 
After thawing of resuspended pellets, 150 µL protease inhibitor PMSF (see Appendix) 
at a final concentration of 1 mM were added to each pellet (obtained from 1 x 600 mL 
bacterial culture) and cells were disrupted by sonification (HD 2070 Bandelin 
Sonopuls SH 706) for 2 x 3 minutes at full power. Next, DNA was digested for 45 
minutes on ice using 20 µL RNase-free DNase I (Fermentas Life Sciences, 1 u/µL). 
Lysate was cleared by centrifugation at 18.000 rpm on 4 °C for 20 minutes (Sorvall 
RC 6. SS-34, Thermo Electron Corporation) and supernatant was subjected to 
immobilized metal affinity chromatography. 
 
2.5.2. IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY (IMAC) 
The supernatant was loaded twice by gravity flow on a 20 mL column (pre-
equilibrated with Equilibration buffer, see Appendix) packed with Ni²+ Sepharose Fast 
Flow resin (GE Healthcare). Bound protein was washed with 2 column volumes of 
Equilibration buffer (see Appendix) and Wash buffer (see Appendix), respectively. 
The protein was eluted with 3 mL Elution buffer (see Appendix), subjected to SDS 
page analysis and to further purification using SEC. 
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2.5.3. SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS 
Protein samples taken from the supernatant, the flow-through, the pellet, the elutions 
and the beads were mixed with an equal amount of SDS loading buffer (see 
Appendix). Samples were heated at 95°C for 5 minutes. 10 µL of each sample and 2 
µL of prestained protein ladder (Fermentas Life Sciences) were loaded onto a 15 % 
SDS- Polyacrylamide gel (preparation see Appendix). Gels were run at 225 V for 45 
minutes.  
 
SDS gels were stained with Coomassie present in the Staining solution (see 
Appendix) for 10 minutes at RT after a short heating period (approximately 10 
seconds) in the microwave. After removing Staining solution, the gel was put into 
Destaining solution (see Appendix) overnight and stored in dd H2O. 
 
2.5.4. BUFFER EXCHANGE 
Buffer exchange of protein elutions from IMAC was carried out using PD-10 or G-25  
desalting columns (GE Healthcare).   
 
2.5.5. SIZE EXCLUSION CHROMATOGRAPHY (SEC) 
Elutions from IMAC were further purified by size exclusion chromatography at 4°C 
using a Superdex 75 10/300 GL column (GE Healthcare). Per run, 600 µL protein 
sample were injected (flow rate: 0,4 mL/min, emptying of 1 mL loop: 1,8 mL).  Unless 
otherwise stated, SEC analysis was performed in SEC buffer (see Appendix).  
 
Calibration of the size exclusion column: A mix of proteins (Table 9) was loaded onto 
the S-75 column to determine a molecular weight calibration curve. The standard 
curve was used to calculate the elution volume of the monomeric GTPase domain-
GED fusion protein: 
 
  
Protein 
C - Conalbumin  
O – Ovalbumin  
CA – Carboanhydrase  
R - Ribonuclease  
Table 9. Protein mix loaded onto the Superdex 75 
 
 
 
 
Figure 6. Calibration curve of S-75 column. Elution volume 
form of the GTPase-GED fusion protein. MW 
 
For further experiments, FPLC fractions containing protein were pooled and 
concentrated up to 10 mg/mL by Amicon Ultra
weight cut off: 10.000; Millipore). Protein 
aliquots of 30 µL were prepared. Purified protein was immediately put into the freezer 
where it was stored at -80°C.
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Molecular 
weight  
Retention 
volume 
75 kDa  9,81 mL  
43 kDa 10,48 mL  
29 kDa  11,87 mL  
13,7 kDa  13,61 mL  
column. 
of 10,98 mL corresponds to the monomeric 
- molecular weight. 
-4 centrifugal filter devices (Molecular 
concentration was determined by UV
  
 
280 and 
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2.6. DYNAMIC LIGHT SCATTERING (DLS)  
In order to check the homogeneity and the oligomerization state of the protein, 
dynamic light scattering was performed: 
Purified protein was diluted to 0,25 mg/mL and 80 µL of the sample were put into a 
disposable, single sealed UVette (50 – 2000 µL, Eppendorf) and measured at 20 °C 
(10 acquisitions á five seconds) by using the DynaProNanoStar Instrument (Wyatt). 
Scattered intensity and radius of the measured particle were plotted in a size 
distribution histogram and percent polydispersity was calculated.  
 
2.7. PROTEIN THERMAL SHIFT ASSAY (THERMOFLUOR ASSAY) 
The Thermofluor assay was performed in order to examine protein stability in 
different buffers:  
 
c (g/mol)   =  c (g/L)      c...concentration 
   M (g/mol)     M...molarity 
 
The protein sample was diluted in a buffer containing 20 mM HEPES and 100 mM 
NaCl , pH 7.4,  to reach an end concentration between 2 and 10 µM in 4 µL.  
Non-specific dye S. Orange (SYPRO Orange protein gel stain) was supplied by 
Invitrogen as a 5000x stock and was diluted to 4,5x in a volume of 6 µL. Buffers were 
pipetted in a 96 well plate (10 µL/well) and 4 µL protein, 6 µL S. Orange and 10 µl of  
2x S. Orange buffer were added. 
Absorbance at 568 nm was plotted against temperature in a melt curve diagram. 
Calculated melting temperatures (Tm) from different conditions were compared.  A 
list of all tested buffers can be found in the Appendix. 
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2.8. CONTINUOUS REGENERATIVE COUPLED GTPASE ASSAY 
GTPase activity of DRP1 (turnover/min) was determined with the continuous, 
regenerative coupled GTPase assay described by Ingerman and Nunnari in 2005 
[31]. 
First, a buffer exchange of the protein into the GTPase Assay buffer (see Appendix) 
was performed. In order to obtain a final concentration of 0,1 mg/mL, a 1,4 mg/mL 
stock of DRP1 was prepared. Likewise, a GTP stock (10 mM) was prepared and 
serially diluted in 25 mM HEPES and 25 mM PIPES. 
 
A mastermix containing 10 µL 20x Reaction buffer (see Appendix), 12 µL 10mM 
NADH, 12 µL 2,3 M NaCl, 126 µL GTPase Assay buffer (see Appendix), 5 µL of a 
pyruvate kinase and lactate dehydrogenase mix (Sigma-Aldric Co.) and 15 µL protein 
was prepared and aliquoted (180 µL/well) into a 96 well plate. 20 µL of the GTP 
stocks were added leading to a final concentration of 0, 10, 25, 50, 100, 250, 500 and 
1000 µM GTP. Absorbance at 340 nm (120 cycles á  20 seconds at 30°C, Infinite M 
200 Tecan) was plotted against time. For final analysis, GTP concentration and 
corresponding GTPase activity (turnover/min) were plotted against each other.  
 
2.9. CRYSTALLIZATION 
The GTPase domain-GED fusion protein used for crystallization was monomeric and 
in SEC buffer (see Appendix). To determine the optimal protein concentration for 
crystallization, a PCT- Pre-Crystallization test (HR-140, Hampton research) was 
performed.  
Initial crystallization screening was performed using the following commercially 
available crystallization screens: Hampton Index screen HR2-144 (Hampton 
research), JCSG-plus screen MD1-37 (Molecular dimensions) and PEG suite. 
0,4 µL protein were mixed with 0,4 µL reservoir solution by using a Hydra II Plus One 
(Matrix Ltd.) liquid-handling system and equilibrated against 50 µL reservoir solution. 
Plates were stored at 4°C/20°C and checked for crystals routinely.  
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Initial hits were refined manually using 96- well intelli plates as well as 24- well plates, 
performing hanging - and sitting-drop vapor diffusion techniques. For fine screening, 
protein and precipitant concentration, and pH were modified. Moreover, additive 
screens, microseeding and streakseeding were performed [32, 33].  
 
2.10. X-RAY DIFFRACTION ANALYSIS 
Suitable crystals were flash-frozen in liquid nitrogen. Initial diffraction measurements 
were performed at an in house X-ray diffractometer using a MAR345 image plate 
system (MAR Research, Hamburg) on a Bruker Microstar rotating anode system at 
100 K.  
An X-ray diffraction data set was collected on beamline ID14-4 at the ESRF 
Grenoble. The beamline was equipped with a Q315r ADSC CCD detector and data 
collection was performed using a wavelength of 1 Å and a crystal-to-detector 
distance of 400 mm. 180 images were collected at 100 K with a 1.0° oscillation 
range. 
Diffraction images were processed by iMOSFLM (Battye et al., 2011) and SCALA 
from the CCP4 program suite (Winn et al., 2011). 
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3. RESULTS  
3.1. CONSTRUCT DESIGN 
Following constructs have been designed: 
 Construct 
name 
Construct 
design 
Cloning Express
-ion 
Purifi- 
cation 
Crystallization/ 
GTPase assay 
DNM1 constructs 
Wildtype E 59* 
E 60* 
M1 – L765 
M1 - L 782 
✓ 
✓ 
   
Full length  
mutations 
G385D  
E 61 
E 62* 
M1 - L765: G385D 
M1 - L782: G385D 
✓ 
✓ 
✓   
 
DRP1 constructs 
GTPase 
domain- 
GED 
fusions 
E 63* 
E 64 
M1 -D328 fused with 
8xGS linker and 
K711 - W736  
✓ 
✓ 
✓ 
✓ 
✓ ✓ 
E 65 
E 66* 
M1 -D328 fused with 
flexible linker and 
K635 - W736 
✓ 
✓ 
✓   
Full length 
mutations 
E 67 
E 68 
E 69 
M1- W 736: A395D 
M1- W 736: G350D 
M1- W 736: G363D 
✓ 
✓ 
✓ 
✓ 
✓ 
✓ 
  
GTPase 
domains  
E 70* 
E 71* 
E 72* 
M1 - S321 
M1 - G323 
M1 - D327 
✓ 
✓ 
✓ 
✓ 
✓ 
✓ 
✓ 
✓ 
✓ 
 
Table 10. Overview of DNM1 and DRP1 constructs. Constructs labeled with a star were cloned by 
Mag. Klinglmayr.  
 
 
 
 
 
3.1.1. DNM1 (YEAST) 
DNM1 (Dynamin-related protein 1) is the yeast ortholog of 
molecular weight of 85 kDa.
domain and a C-terminal GTPase effector domain (GED).
G385D mutation have been 
and a C-terminal His-tag to the construct, resp
located in the middle domain and
 
3.1.2. DRP1 (HUMAN) 
DRP1 (Dynamin-related protein 1) is a 82,9 kDa protein. It consists of a N
GTPase domain and a middle domain, whic
the C-terminal GTPase effector domain.
 
 
Figure 7. Domain architecture of DRP1. GED 
 
Fusion constructs E 63 – E 66
pET-21, attaching a N- and a C
and E 64 are 1422 bp long fusions of the GTPase domain and the C
the GED, connected with a glycine
domain, they cannot form higher oligomer
according to the human dynamin 1
protein, crystallized by Chappie et al in 2010 [16].
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DRP
 It consists of a N-terminal GTPase domain, a middle 
 DNM1 full length and 
cloned into pHIS-Parallel2 and pET-21, attaching a N
ectively. The G385D substitution is 
 was described to form a stable dimer [15].
h is linked via a flexible linke
 
– GTPase effector domain. 
 have been cloned into the vector pHIS
-terminal His-tag to the construct, respectively. E 63 
-serine linker. Since these proteins lack the middle 
s. Construct design was performed 
-derived minimal GTPase domain
 
1 and has a 
a 
- 
 
-terminal 
r region to 
 
-Parallel2 and 
-terminal part of 
-GED fusion 
  
Figure 8. Domain architecture of
shown. GS linker – Glycine-serine linker, GED 
 
E 65 and E 66 are similar fusion constructs
flexible linker region and the whole GTPase effector domain.
 
 
Figure 9. Domain architecture of 
shown. Flex. Linker – Flexible linker region. GED 
 
Mutation constructs E 67 
mutations A395D, G350D -
and G363D.  
 
 
Figure 10. Domain architecture of constructs E 67, E 68 and E 69
Blue stars indicate sites of mutation.
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 constructs E 63/E 64.The N-terminal/ C-terminal His
– GTPase effector domain. 
, containing an additional
 
constructs E 65/ E 66. The N-terminal/ C-terminal His
– GTPase effector domain. 
– E 69 are full length DRP1 constructs carrying the 
 which corresponds to the G385D substitution in yeast 
. GED – GTPase 
 
 
-tag is not 
 part of the 
 
-tag is not 
- 
 
effector domain. 
All of these mutated amino acids are located in the middle domain,
across different species (Figure
assembly and mitochondrial fi
tetramers, but not higher oligomers. A395D mutants exist mainly in a dimeric state 
[11]. 
 
H. sap.  EPVDDKSATLLQLITKFATEYCNTIE
M. musc. EPVDDKSATLLQLITKFATEYCNTIE
C. ele.  EPVEDKNRTLLQIITRFATAYTSTIE
S. cere. TTNESRASLVLQLMNKFSTNFISSID
          . :.:   :**::.:*:* : .:*:**:  *:*.******** **:::.**.:*:*::*
 
H. sap.  LGGLNTIDILTAIRNATGPRPALFVPEVSFELLVKRQIKRLEEPSLRCVELVHEEMQRII 443
M. musc. LGGLNTIDILTAIRNATGPRPALFVPEVSFELLVKRQIKRLEEPSLRCVELVHEEMQRII 449
C. ele.  LENLTQLDILTAIRNATGPRPALFVPEVSFELLVKRQIQRLEEPSLRCVELVHEEMQRMV 445
S. cere. TSNLSVLDVRTAIRNSTGPRPTLF
           .*. :*: *****:*****:*****::*:**** **: * *** ******:**: :: 
 
Figure 11. Section of a multiple sequence alignment (obtained from ClustalW2) of DRP1 and its 
orthologs in different species showing conserved amino acids in the middle domain. 
Dynamin related protein 1 from H. 
like protein from M. musculus (UniProt
from C. elegans (UniProt-number Q9U4L0) and 
cerevisiae (UniProt-number:  P5486
 
Finally, already existing GTPase 
subcloned into pHIS-Parallel 2, in order to attach a N
to increase crystallization probability.
72. 
 
Figure 12. Domain architecture of constructs E 70, E 71 and E 72.
shown.  
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 11) and have been described to inhibit higher order 
ssion: G350D - and G363D mutants are able to form 
GTAKYIETSELCGGARICYIFHETFGRTLESVDP 383
GTAKYIETSELCGGARICYIFHETFGRTLESVDP 389
GTARNIETTELCGGARICYIFHDTFGRSLESVNP 385
GTSSDINTKELCGGARIYYIYNNVFGNSLKSIDP 418
VPELAFDLLVKPQIKLLLEPSQRCVELVYEELMKIC 478
sapiens (UniProt-number: O00429), M. musc. refers to 
-number: Q8K1M6), C. ele. refers to Dynamin related protein 1 
S. cere. refers to Dynamin-related protein 1 from S. 
1). 
domain constructs in the lab of different
-terminal His tag to the protein 
 These constructs are termed 
 The N-terminal His
highly conserved 
 
 
 
 
 
 
 
 
 
 
H. sap.refers to 
Dynamin 1-
 length were 
E 70, E 71 and E 
 
-tag is not 
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3.2. BIOINFORMATIC ANALYSIS OF THE DRP1 GTPASE DOMAIN-
GED FUSION PROTEIN 
The DNA sequence of DRP1 was obtained from NCBI (NCBI Reference Sequence: 
NP_036192.2, UniProt number: O00429, listed in the Appendix).    
 
The amino acid sequence of the GTPase domain-GED fusion protein: 
 
        10         20         30         40         50         60  
MEALIPVINK LQDVFNTVGA DIIQLPQIVV VGTQSSGKSS VLESLVGRDL LPRGTGIVTR  
 
        70         80         90        100        110        120  
RPLILQLVHV SQEDKRKTTG EENGVEAEEW GKFLHTKNKL YTDFDEIRQE IENETERISG  
 
       130        140        150        160        170        180  
NNKGVSPEPI HLKIFSPNVV NLTLVDLPGM TKVPVGDQPK DIELQIRELI LRFISNPNSI  
 
       190        200        210        220        230        240  
ILAVTAANTD MATSEALKIS REVDPDGRRT LAVITKLDLM DAGTDAMDVL MGRVIPVKLG  
 
       250        260        270        280        290        300  
IIGVVNRSQL DINNKKSVTD SIRDEYAFLQ KKYPSLANRN GTKYLARTLN RLLMHHIRDC  
 
       310        320        330        340        350        360  
LPELKTRINV LAAQYQSLLN SYGEPVDGSG SGSGSKEAAD MLKALQGASQ IIAEIRETHL  
 
 
WLEHHHHHH  
Figure 13. Amino acid sequence of the GTPase domain-GED fusion protein (D328 fused with K711) 
showing the N-term. GTPase in green, the core GTPase in purple, the C-term. GTPase domain in 
yellow, two amino acids that already belong to the middle domain in blue, the glycine-serine linker in 
black, the GED in red and the C-term. His tag in pink. Colouring is the same as in figure 8.  
 
The 369 amino acid long GTPase domain-GED fusion protein has a molecular weight 
of 40 923 Da and a theoretical pI of 6.32 (according to Expasy ProtParam). 
 
Model of the GTPase domain-GED fusion protein 
Due to the sequence conservation of 36 % between full length DRP1 and human 
dynamin (52 % between GTPase domains, Figure 14), a homology model of the 
DRP1 GTPase domain-GED fusion protein based on the crystal structure of dynamin 
GG dimer (PDB ID 2X2E) was created (Figure 15). 
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Figure 14. Sequence alignment of human dynamin 1 (
related protein 1 (UniProt number: O00429
clustering (F. Corpet, 1988, Nucl. Acids Res., 16 (22), 10881
are shown in red. 
 
 
Figure 15. Homology model of the
2X2E (Chappie et al, 2010) and was created using FFAS. 
is coloured in green, the core in purple and the C
and the C-terminal part of the GED in red.
domain. Figure was created with Pymol (Version 1.3).
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UniProt number: Q05193) with human dynamin
) created with Multiple sequence alignme
-10890). Identical amino acid residues 
 GTPase domain-GED fusion protein. Model is based on PDB entry 
The N-terminal part of the GTPase domain 
-terminal part in yellow. GS linker is shown in black 
 GS linker – Glycine-serine linker, GED 
 
-
nt with hierarchical 
– GTPase effector 
3.3. CLONING 
Cloning of DNM1 and DRP1 constructs worked 
checked by sequencing. 
 
3.4. PROTEIN EXPRESSION
3.4.1. EXPRESSION OF 
Whereas expression of DNM1 wildtype proteins
mutation protein E 62 failed, mutation protein E 61 showed  moderate expression.
 
 
Figure 16. SDS-PAGE of DNM1 wildtype and mutation proteins after IMAC. M 
supernatant, P – pellet, F – flow-
62: 88 kDa. 
 
3.4.2. EXPRESSION OF 
Expression of short GTPase domain
very well, whereas the expression of longer fusion 
show high protein amounts.
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very well and all constructs were 
 
DNM1 CONSTRUCTS E 59 – E 62 
 (E 59 and E 60) and the G385D 
through, E – elution, B – beads.  E 59 and E 61: 86 kDa, E 60 and E 
DRP1 CONSTRUCTS E 63 – E 72  
-GED fusion proteins (E 63 and E 64) worked 
proteins (E 65 and E 66) did not 
 
 
 
– marker, SN – 
 Figure 17. SDS-PAGE of DRP1 
supernatant, P – pellet, F – flow-
kDa, E 66: 51 kDa. 
 
The expression of mutation constructs (E 67 
amount. 
 
 
Figure 18.  SDS-PAGE of DRP1 mutation constructs E 67, E 68 and E 69 after IMAC. M 
– supernatant, P – pellet, F – flow
 
Likewise, expression of GTPase domain constructs (E 70 
successful. 
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GTPase domain-GED fusion proteins after IMAC. M 
through, E – elution, B – beads. E 63: 41 kDa, E 64: 43 kDa, E 65:49 
– E 69) yielded a very high protein 
-through, E – elution, B – beads. E 67, E 68 and E 69: 83 kDa.
– 
 
– marker, SN – 
 
– marker, SN 
 
E 72) was very 
  
 
 
 
 
 
Figure 19. SDS-PAGE of DRP1 GTPase 
marker, SN – supernatant, P – pellet, F 
~39 kDa. 
3. 5. EXPRESSION AND SUBSEQ
GTPASE DOMAIN-GED
As mentioned above, the 
terminal GTPase domain that was fused to the C
glycine-serine linker. 
 
 
Figure 20. Domain architecture of the GTPase domain
The C-terminal His-tag is not shown. GS linker 
domain. 
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domain constructs E 70, E 71 and E 72 after IMAC. M 
– flow-through, E – elution, B – beads. E 70, E 71 and E 72: 
UENT PURIFICATION OF
 FUSION PROTEIN 
GTPase domain-GED fusion protein consists of a N
-terminal part of the GED via a 
-GED fusion protein. 
– Glycine-serine linker, GED 
– 
 THE 
-
 
– GTPase effector 
The protein expression worked 
 
Figure 21. SDS-PAGE of the GTPase domain
flow-through, E – elution. 
 
Since the expression level of this protein showed the highest yield, 
purification step was carried out
 
 
 
Figure 22. A. SEC analysis of 
retention volume of 10,89 mL. B.
exclusion chromatography.  
 
A 
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very well (Figure 21).  
 
-GED fusion protein. M – marker, SN 
:  
 
 
the GTPase domain-GED fusion protein. The protein elutes at a 
 SDS PAGE of the GTPase domain-GED fusion protein after size 
B 
– supernatant, F – 
a second 
Most of the protein eluted at a retention volume of 10,89 mL
monomer when compared with a previously perform
and Methods). SDS-PAGE analysis shows that the protein is 99% pure
important determinant for successful c
 
3.6. DLS ANALYSIS 
In order to evaluate the homogeneity of the protein sample and to decide whether or 
not the protein sample should be sterile filtered prior to crystallization, d
scattering was performed [34, 35, 36].
 
 
            A.  
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 which corresponds to a 
ed standard curve (see Material
rystallization. 
 
 
. Purity is an 
ynamic light 
 
            B.  
    
Figure 23. DLS analysis of the GTPase
left untreated (B.).  
 
The size distribution histograms of both samples show a single peak (monomodal 
size distribution). The polydispersity of the untreated protein is lower (17,5%) than 
that of the sterile filtered sample (34,4%). Thus, the unfiltered protein was used for 
crystallization experiments. 
 
3.7. THERMOFLUOR ASSAY
In order to analyze the stability o
different buffers, a thermofluor assay was performed using 3,7 µM DRP1 fusion 
protein: 
 
 
 
 
 
 
 
 
A. 
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-GED fusion protein sterile filtered prior to measurement (
 
f the protein after size exclusion chromatography in 
 
A.) or 
B. 
 
Figure 24. Melting temperature diagram of 
buffer after size exclusion chromatography
 
The GTPase domain-GED fusion protein is more stable in buffers around neutral pH. 
Acidic pH has a negative effect on the stability of the protein. Moreover, it i
stable when guanine nucleotide analogs
hydrolyzable GTP analog 
effect.  
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the DRP1 GTPase domain-GED fusion protein in SEC 
 in buffers of different pH (A.) and with additives (
 GDP, GTP or GMP
- are added. Addition of 40 % Glycerol shows a similar 
 
 
B.). 
s more 
-PCP -  a non 
3.8. OLIGOMERIZATION STATE
GED FUSION PROTEIN UPON 
ANALOGS 
Before incubation of the DRP1 
nucleotide analogs, a buffer exchange into SEC 2 buffer (see Appendix) was 
performed. The protein was incubated with either 1 mM GDP, 1 mM GTP or 1 mM 
GMP-PCP for 30 minutes at room temperature and then analyzed by 
In parallel, a buffer exchange into a buffer containing 4 mM MgCl₂, 2 mM EGTA and 
1 mM DTT (SEC 3 buffer, see Appendix) was performed. The DRP1 
domain-GED fusion protein was incubated
mM AlCl3 and 20 mM NaF for 30 minutes at 37°C and then analyzed by SEC. The 
experimental setup was designed according to Chappie et al in 2010 [16].
 
Figure 25. SEC analysis of the 
GDP (blue), 1 mM GTP (red), 1 mM GMP
AlCl3 and 20mM NaF, light blue).
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S OF THE DRP1 GTPASE DOMAIN
ADDITION OF GUANINE NUCLEOTIDE 
GTPase domain-GED fusion protein with guanine 
 with transition state mimic 2 mM GDP, 2 
GTPase domain-GED fusion protein in the presence of 
-PCP (green) or transition state mimic (2mM GDP, 2mM 
  
-
 
 
SEC. 
GTPase 
 
 
either 1 mM 
As shown in figure 25, the addition of neither GDP nor GTP nor GMP
oligomerization state of the 
eluted again at a retention volume of ~10,9 mL.
mimic eluted mainly as a dimer at a retention volume of ~9,4 mL.
 
3.9. GTPASE ASSAY 
For further protein characterization, a buffer exchange into 25 mM HEPES, 
25 mM PIPES and 150 mM NaCl (GTPase assay buffer, see Appendix) was 
performed after size exclusion chromatography. Subsequently, DRP1 full length 
protein and GTPase domain
activity with a continuous, regenerative coupled GTPase assay for dynamin
proteins [31]:  
 
 
Figure 26. GTPase assay of wildtype DRP1 and GTPase domain
 
As shown in figure 26, the wildtype protein 
than the GTPase domain-GED fusion protein at a GTP concentration of 0,5 mM.
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GTPase domain-GED fusion protein: The monomer 
 However, the DRP1 transition s
 
-GED fusion protein were assayed for their GTPase 
-GED fusion protein.
exhibits a fivefold higher GTPase activity 
-PCP alters the 
tate 
 
-related 
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3.10. CRYSTALLIZATION 
The GTPase-GED fusion protein used for crystallization was monomeric and in SEC 
buffer. Initial crystallization screening was performed using several commercially 
available crystallization screens. 
 
Initial hits were obtained at following conditions:  
 1. 0,1 M sodium citrate pH 5,5 20 % (w/v) PEG 3000 (day 1) 
 2. 0,2 M lithium sulfate 0,1 M Bis-Tris pH 5,5 25% (w/v) PEG 3350 (day 11) 
 
  A.             
 
      B.  
 
 
 
 
 
 
Figure 27. GTPase domain-Ged fusion protein crystals. A. Initial hit observed after 1 day in 0,1 M 
sodium citrate pH 5,5 20 % (w/v) PEG 3000. B. Initial hit in 0,2 M lithium sulfate, 0,1 M Bis-Tris pH 5.5, 
25 % (w/v) PEG 3350 after 11 days. 10,4 mg/mL monomeric protein was used. 
 
First, the condition containing lithium sulfate and Bis-Tris was used. Initial hits were 
refined manually, performing hanging - and sitting-drop vapor diffusion techniques 
[37, 38, 39]. For fine screening protein and precipitant concentration, and pH were 
modified [40, 41, 42]. 
 
 
 
 
 
Figure 28. Refined GTPase domain
Bis-Tris pH 5 and 25% (w/v) PEG 3350. 
 
Thin plates from these crystals were broken and 
crystals showed diffraction (see X
data was not good enough to enable further data processing. 
optimization was attempted
Therefore, refinement of crystals i
performed (Figure 29). 
 
         A.    
 
 
 
 
 
 
 
 
Figure 29. A. and B. show refined 
protein. 
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-GED fusion protein crystals, grown in 0,2 M lithium 
10,4 mg/mL monomeric protein was used.
flash-frozen in liquid nitrogen. These 
-ray diffraction analysis), however, the q
. Unfortunately, reproduction of these
n the condition containing sodium citrate 
        B. 
crystals of 9,6 mg/mL monomeric GTPase domain
sulfate, 0,1 M 
 
uality of the 
Thus, further 
 crystals failed. 
was 
-GED fusion 
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3.11. X-RAY DIFFRACTION ANALYSIS 
Initial diffraction experiments were performed at an in-house rotating anode facility, to 
check that the crystals are protein and not salt.  
An X-ray diffraction data set was collected on beamline ID14-4 at the ESRF Grenoble  
to a resolution of 4 Å. We thank Ulrich Eckhard for data collection.The orthorhombic 
crystals were indexed with space group P2 and unit cell parameters a = 42.15, b = 
53.31, c = 150.54 Å. Since the collected data showed only limited diffraction due to 
ice rings and high anisotropy, further data processing failed. 
 
 
 
Figure 30. 1.0° Oscillation image of the DRP1  
GTPase domain-GED fusion protein crystal  
collected at ESFR Grenoble.Thanks for data 
collection to Ulrich Eckhard. 
 
 
 
 
 
 
 
 
DRP1 GTPase domain-GED fusion  
protein  
Space Group  P2 
Cell dimensions     
     a (Å)  42,15  
     b (Å) 53,31  
     c (Å) 150,54 
     α, β, ɣ (°) 90/90/90 
Resolution (Å) 4 
Table 11. Data statistics of the DRP1 
GTPase domain-GED fusion protein. 
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4. DISCUSSION 
 
In order to characterize dynamin related protein 1, several constructs were designed: 
Out of 10 constructs, 9 could be successfully expressed in E. coli and purified by 
IMAC. 4 constructs were further purified using SEC. For all DNM1 constructs, 
expression in E. coli did not yield sufficient protein amounts. 
For several reasons just the DRP1 GTPase domain-GED fusion protein (construct E 
63) was characterized: Expression of the GTPase domain-GED fusion protein 
showed a high protein yield (approximately 3,3 mg/L culture). Unlike full length 
constructs, this protein contains no flexible linker region which might prevent 
crystallization. The GTPase domain-GED fusion protein is more stable than the 
GTPase domain constructs, because backfolding of the C-terminus of the GED is 
known to stabilize the protein. Moreover, the crystal structure of the corresponding 
construct in dynamin 1 was successfully solved by Chappie et al in 2010 [16].  
 
It could be established that the GTPase domain-GED fusion protein is a functional 
GTPase which behaves as expected: The GTPase activity is lower than that of the 
wildtype protein due to impaired oligomerization and SEC analysis revealed dimer 
formation upon incubation with transition state mimics GDP, NaF and AlCl3. Thus, the 
GTPase domain-GED fusion protein was further analyzed by DLS, Thermofluor, 
GTPase assay and crystallization. Furthermore, analytical SEC runs were performed 
upon addition of guanine nucleotide analogs and transition state mimics: 
 
Dynamic light scattering analysis of the GTPase domain-GED fusion protein yielded 
a polydispersity of 17,5%,  a value that can be considered relatively low. As a general 
rule, it can be stated that a lower polydispersity displays a higher homogeneity of the 
sample and therefore a higher probability of crystallization. For DRP1, sterile filtration 
prior to crystallization was less favorable due to a higher degree of inhomogeneity. 
However, it can be assumed that this may be caused by interactions of the protein 
with the hydrophobic membrane of the filter, which may lead to partial unfolding.  
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In conformity with the size exclusion chromatography results, DLS showed that the 
majority of the protein exists as one distinct oligomerization state, namely as 
monomer. 
Thermofluor assays showed that the GTPase domain-GED fusion protein is most 
stable in buffers with pH around 8 and upon incubation with 10 mM GDP,10 mM GTP 
10 mM GMP-PCP and 40 % Glycerol, respectively.  
Analytical SEC runs revealed that the oligomerization state of the GTPase domain-
GED fusion protein is not altered upon addition of either GDP, GTP or GMP-PCP. In 
the presence of GDP, NaF and AlCl3, however, DRP1 fusion protein dimerized. This 
fact implies that the DRP1 GTPase-GED fusion construct is functional and behaves 
like previously published for the human dynamin [16].  
Chappie et al [16] confirmed that only upon assembly of two semi-functional GTPase 
domains, the contribution of  amino acid residues from both results in a fully 
functional catalytic center explaining a key feature of dynamin superfamily members, 
namely the assembly-stimulated GTPase activity. 
Analysis of the GTPase activity showed that the GTPase domain-GED fusion protein 
exhibits a fivefold lower activity than the wildtype. Since the fusion protein lacks the 
middle domain, which plays an important role in self-assembly, it can only form 
dimers, but not higher oligomers, impairing assembly-stimulated GTPase activity. 
 
In summary, the successful expression and purification of the monodisperse DRP1 
GTPase domain-GED fusion protein that existed as a stable monomer was achieved. 
The protein shows GTPase activity and is able to dimerize in presence of the 
transition state mimics. Furthermore, the successful crystallization of the GTPase 
domain-GED fusion protein was achieved; the most important step for solving its 
crystal structure. Additional experiments are underway. 
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5. SUMMARY 
 
The aim of this study was the biochemical and biophysical characterization of human 
dynamin-related protein 1 (DRP1), the main mitochondrial division factor.  
 
Mitochondria are considered to play a crucial role in energetic metabolism, apoptosis 
and calcium homeostasis. In oder to accomplish their functions, they undergo 
frequent fission and fusion, which is very important in tissues with high dependence 
on energy supply, such as neurons. Mitochondrial dynamics are mediated by a group 
of large, self-assembling GTPases; the most important in humans are DRP1 and 
fusion factors mitofusins and OPA1. 
Obviously, dysfunction or misregulation of mitochondrial dynamics leads to 
neurodegenerative disorders like Charcot-Marie-Tooth disease, Alzheimer´s -, 
Parkinson´s - and Huntington´s disease. 
In the last-mentioned disorder, elevated levels of GTPase activity of DRP1 have been 
shown to result in excessive mitochondrial fragmentation which causes neuronal cell 
death. 
Thus, DRP1 might be a new target for drug design in treatment of this disease. 
Therefore solving its crystal structure is of high clinical relevance and great scientific 
interest. 
 
Here we report the successful cloning, expression and crystallization of the DRP1 
GTPase domain-GED fusion protein. Initial diffraction data are promising and we are 
confident that its crystal structure will be soon solved. 
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6. ZUSAMMENFASSUNG 
 
Das Ziel dieser Studie war die Charakterisierung des Proteins DRP1 (dynamin 
related protein 1), der Hauptfaktor bei der mitochondrialen Teilung, auf 
biochemischer und biophysikalischer Ebene. 
Mitochondrien spielen unter anderem im Energiehaushalt, in der Apoptose und der 
Homöostase von Kalzium eine entscheidende Rolle. Um diese Funktionen zu 
erfüllen, teilen sie sich kontinuierlich und verschmelzen wieder. Dies ist besonders 
wichtig in Gewebe, das stark von der Energieversorgung durch diese Organellen 
abhängt, wie die Neuronen. Dieser dynamische Prozess wird von einer Gruppe von 
großen GTPasen ausgeführt, welche selbst zu höheren Oligomeren assemblieren. 
Zu den wichtigsten Vertretern im Menschen zählen DRP1 und die bei 
Verschmelzungsprozessen involvierten Proteine, OPA1 und Mitofusine. 
Naturgemäß führt eine Funktionsstörung oder ein Fehler in der Regulation der 
mitochondrialen Dynamik zu degenerativen Krankheiten des Nervensystems wie zum 
Beispiel: Charcot-Marie-Tooth-Syndrom, Alzheimer-Krankheit, Parkinson-Krankheit 
und Chorea Huntington. 
In der letztgenannten Störung führt eine erhöhte GTPase Aktivität von DRP1 zu einer 
übermäßigen Fragmentierung von Mitochondrien, welche in weiterer Folge das 
Absterben von Nervenzellen verursacht. 
 
DRP1 spielt daher eine bedeutende Rolle bei der Suche nach Medikamenten gegen 
Chorea Huntington. Und aus eben diesem Grund ist die Aufklärung seiner Struktur 
nicht nur von großem, wissenschaftlichen Interesse sondern auch von bedeutender, 
klinischer Relevanz.  
 
Diese Arbeit berichtet von der erfolgreichen Klonierung, Expression, Reinigung und 
Kristallisation des DRP1-Proteins, in welchem die GTPase Domäne mit der GED 
fusioniert wurde. Erste Untersuchungsergebnisse mittels Röntgenstrukturanalyse 
sind sehr vielversprechend und wir sind zuversichtlich, dass die Kristallstruktur von 
DRP1 in naher Zukunft gelöst wird. 
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APPENDIX 
1. SEQUENCES  
1.1. DNA SEQUENCE OF DRP1  
DNA sequence was obtained from NCBI (NCBI Reference Sequence: NM_012062.3) 
 
ORIGIN       
        1 gcatggcctg ccgggagggg gcaggtagcc ggcgggcccg gtccaatggg tgccggcttc 
       61 cgaggagagg gcggaggaga ggaggaagga ggcgaactgt gggccccggc cccattcatt 
      121 gccgtggccg gcgggcactg gggccccgtg ttttcagagt catggaggcg ctaattcctg 
      181 tcataaacaa gctccaggac gtcttcaaca cggtgggcgc cgacatcatc cagctgcctc 
      241 aaatcgtcgt agtgggaacg cagagcagcg gaaagagctc agtgctagaa agcctggtgg 
      301 ggagggacct gcttcccaga ggtactggaa ttgtcacccg gagacctctc attctgcaac 
      361 tggtccatgt ttcacaagaa gataaacgga aaacaacagg agaagaaaat ggggtggaag 
      421 cagaagaatg gggtaaattt cttcacacca aaaataagct ttacacggat tttgatgaaa 
      481 ttcgacaaga aattgaaaat gaaacagaaa gaatttcagg aaataataag ggagtaagcc 
      541 ctgaaccaat tcatcttaag attttttcac ccaacgttgt caatttgaca cttgtggatt 
      601 tgccaggaat gaccaaggtg cctgtaggtg atcaacctaa ggatattgag cttcaaatca 
      661 gagagctcat tcttcggttc atcagtaatc ctaattccat tatcctcgct gtcactgctg 
      721 ctaatacaga tatggcaaca tcagaggcac ttaaaatttc aagagaggta gatccagatg 
      781 gtcgcagaac cctagctgta atcactaaac ttgatctcat ggatgcgggt actgatgcca 
      841 tggatgtatt gatgggaagg gttattccag tcaaacttgg aataattgga gtagttaaca 
      901 ggagccagct agatattaac aacaagaaga gtgtaactga ttcaatccgt gatgagtatg 
      961 cttttcttca aaagaaatat ccatctctgg ccaatagaaa tggaacaaag tatcttgcta 
     1021 ggactctaaa caggttactg atgcatcaca tcagagattg tttaccagag ttgaaaacaa 
     1081 gaataaatgt tctagctgct cagtatcagt ctcttctaaa tagctacggt gaacccgtgg 
     1141 atgataaaag tgctacttta ctccaactta ttaccaaatt tgccacagaa tattgtaaca 
     1201 ctattgaagg aactgcaaaa tatattgaaa cttcggagct atgcggtggt gctagaattt 
     1261 gttatatttt ccatgagact tttgggcgaa ccttagaatc tgttgatcca cttggtggcc 
     1321 ttaacactat tgacattttg actgccatta gaaatgctac tggtcctcgt cctgctttat 
     1381 ttgtgcctga ggtttcattt gagttactgg tgaagcggca aatcaaacgt ctagaagagc 
     1441 ccagcctccg ctgtgtggaa ctggttcatg aggaaatgca aaggatcatt cagcactgta 
     1501 gcaattacag tacacaggaa ttgttacgat ttcctaaact tcatgatgcc atagttgaag 
     1561 tggtgacttg tcttcttcgt aaaaggttgc ctgttacaaa tgaaatggtc cataacttag 
     1621 tggcaattga actggcttat atcaacacaa aacatccaga ctttgctgat gcttgtgggc 
     1681 taatgaacaa taatatagag gaacaaagga gaaacaggct agccagagaa ttaccttcag 
     1741 ctgtatcacg agacaagtct tctaaagttc caagtgcttt ggcacctgcc tcccaggagc 
     1801 cctcccccgc tgcttctgct gaggctgatg gcaagttaat tcaggacagc agaagagaaa 
     1861 ctaaaaatgt tgcatctgga ggtggtgggg ttggagatgg tgttcaagaa ccaaccacag 
     1921 gcaactggag aggaatgctg aaaacttcaa aagctgaaga gttattagca gaagaaaaat 
     1981 caaaacccat tccaattatg ccagccagtc cacaaaaagg tcatgccgtg aacctgctag 
     2041 atgtgccagt tcctgttgca cgaaaactat ctgctcggga acagcgagat tgtgaggtta 
     2101 ttgaacgact cattaaatca tattttctca ttgtcagaaa gaatattcaa gacagtgtgc 
     2161 caaaggcagt aatgcatttt ttggttaatc atgtgaaaga cactcttcag agtgagctag 
     2221 taggccagct gtataaatca tccttattgg atgatcttct gacagaatct gaggacatgg 
     2281 cacagcgcag gaaagaagca gctgatatgc taaaggcatt acaaggagcc agtcaaatta 
     2341 ttgctgaaat ccgggagact catctttggt gaagagaact atgtaatact gagactttgt 
     2401 tgactcaaaa cttgctagtt actgcctacc tgagtagaat cttatttatg aactcctgtg 
     2461 tattgcaatg gtatgaatct gctcatgtgg agactggcta taaactgaaa agtgtattcc 
     2521 aaattgcaga acacatcaca catttaatcc aaataataaa tggctgtttc taaagtttcc 
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     2581 cagtatatat aaaatacatc aagtctgtct tgtgacagtt tcatctgaac ttaacttaaa 
     2641 aacaactgtt aatgttctag ttgtgcaaag cagtttgcct gtggataaga tgacctgtgt 
     2701 aataatcttt gttagtagtc ttaaagctgc tgccatagtc ctccaagaag aaagcaccaa 
     2761 gacaacattt catatgacta taatgcatgt actatataag ctgatctggc tttgaaagat 
     2821 gtgagttggc aagttcctca catagagtca ttgtattcca cctgtccttc aatttagttt 
     2881 tttctgagct tctttgcagc ctttgatgtg tttttaagaa agctgaatgc acaagaggat 
     2941 ctgtgacact gacatggctg tggtgtgcat actgtgtagt tacatagccc ttccaattct 
     3001 gggtccattt gcactagcaa attaaaatat gctttgattc atacttaaac ctgaaagcag 
     3061 gaatgcctac attaattcct acattaaaaa cagccatcta cccttgatta tctagaaaga 
     3121 cttggtaatg atggtcagtt ccttttagat ttcagaaaat caaatgatga cctaaatttc 
     3181 ccttaatttg caaatacagt agtaattaag gtacatctct aaagtggagc acttacacca 
     3241 ggctctaaga ttcactttga ggtggaactt aaaaccagtg tactgtatgt atgcattggt 
     3301 aatagctact tttgcttcat agcttcatac caacaaaata tatttattag aatagtatga 
     3361 aagtactgga ggagctgaaa gaaaaacacc caaggctggg cgtggtggca cacgcctgta 
     3421 atcccagcac tttgggaggc cgaggcaggt ggatcacctg aggttgggag ttggagacca 
     3481 gcttgaccaa catggagaaa ccccgtctct actaaaaata caaaattggc cgggcgtggt 
     3541 ggcgcatgcc tgtaatccca gctactcggg agggtgaggc aggagaattg cttgaccctg 
     3601 ggaggtggag gttgtggtga gctaagatcg tgccattgca ctccagcctt ggcaacaaga 
     3661 gcgaaactcc gtctcaaaaa aaaaaaataa aacaacaccc agatagatac acatactcct 
     3721 tcagacttac agacctaagc tgcatttatg gggtagtgat gaggtttaga acatatacat 
     3781 attttgttaa aattccccag atgattcttg gtatgaacga ctatattata aattttaaga 
     3841 tgtacttaga aatccttaag acatctagcc ccgtctctaa tagacaacac atttatattg 
     3901 cagatattac ttttttttca gtttatgacc aggtatttat gaaggactat tggcagggaa 
     3961 aatatgaata tgttaacttt agcttatggc atcaatttac taaggaacaa caggctcacc 
     4021 aactgatgtc aaacataaaa acccccacat cagtctgata cgatatggta ctactttgaa 
     4081 tctgttacta gtaccatctt gacagaggat acatgctccc aaaacgtttg ttaccacact 
     4141 taaaaatcac tgccatcatt aagcatcagt ttcaaaatta tagccattca tgatttactt 
     4201 tttccagatg actatcatta ttctagtcct ttgaatttgt aaggggaaaa aaaacaaaaa 
     4261 caaaaactta cgatgcactt ttctccagca catcagattt caaattgaaa attaaagaca 
     4321 tgctatggta atgcacttgc tagtactaca cactttgtac aacaaaaaac agaggcaaga 
     4381 aacaacggaa agagaaaagc cttcctttgt tggcccttaa actgagtcaa gatctgaaat 
     4441 gtagagatga tctctgacga tacctgtatg ttcttattgt gtaaataaaa ttgctggtat 
     4501 gaaatgacac taaagtttgt caaaaaatga attcttaact tttctcccag agaaagggag 
     4561 acaaaaggag ctttttaata cctaatctac tttggaacat aaccgtatag ag 
// 
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1.2. AMINO ACID SEQUENCE OF DRP1 
Amino acid sequence was obtained from UniProtKB (UniProt number: O00429): 
 
        10         20         30         40         50         60  
MEALIPVINK LQDVFNTVGA DIIQLPQIVV VGTQSSGKSS VLESLVGRDL LPRGTGIVTR  
 
        70         80         90        100        110        120  
RPLILQLVHV SQEDKRKTTG EENGVEAEEW GKFLHTKNKL YTDFDEIRQE IENETERISG  
 
       130        140        150        160        170        180  
NNKGVSPEPI HLKIFSPNVV NLTLVDLPGM TKVPVGDQPK DIELQIRELI LRFISNPNSI  
 
       190        200        210        220        230        240  
ILAVTAANTD MATSEALKIS REVDPDGRRT LAVITKLDLM DAGTDAMDVL MGRVIPVKLG  
 
       250        260        270        280        290        300  
IIGVVNRSQL DINNKKSVTD SIRDEYAFLQ KKYPSLANRN GTKYLARTLN RLLMHHIRDC  
 
       310        320        330        340        350        360  
LPELKTRINV LAAQYQSLLN SYGEPVDDKS ATLLQLITKF ATEYCNTIEG TAKYIETSEL  
 
       370        380        390        400        410        420  
CGGARICYIF HETFGRTLES VDPLGGLNTI DILTAIRNAT GPRPALFVPE VSFELLVKRQ  
 
       430        440        450        460        470        480  
IKRLEEPSLR CVELVHEEMQ RIIQHCSNYS TQELLRFPKL HDAIVEVVTC LLRKRLPVTN  
 
       490        500        510        520        530        540  
EMVHNLVAIE LAYINTKHPD FADACGLMNN NIEEQRRNRL ARELPSAVSR DKSSKVPSAL  
 
       550        560        570        580        590        600  
APASQEPSPA ASAEADGKLI QDSRRETKNV ASGGGGVGDG VQEPTTGNWR GMLKTSKAEE  
 
       610        620        630        640        650        660  
LLAEEKSKPI PIMPASPQKG HAVNLLDVPV PVARKLSARE QRDCEVIERL IKSYFLIVRK  
 
       670        680        690        700        710        720  
NIQDSVPKAV MHFLVNHVKD TLQSELVGQL YKSSLLDDLL TESEDMAQRR KEAADMLKAL  
 
       730  
QGASQIIAEI RETHLW  
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2. CLONING 
2.1. PRIMERS 
Primer sequences for site-directed mutagenesis were designed with the bioinformatic 
tool PrimerX (http://www.bioinformatics.org/primerx/) and obtained from Eurofins 
MWG Operon (100 µM). 
 
DNM1 primers:  
E 61:  
Ep 10f 5´ – CTGGTCATATGGCTAGTTTAGAAGATC – 3´ 
Ep 10r 5´- CTGGTCTCGAGCAGAATATTACTAATAAGGG – 3´ 
 
DRP1 primers: 
Ep 6f 5´ – CTGGTCATATGGAGGCGCTAATTCCTGTC- 3´ 
Ep 6r 5´ – CTGGTCTCGAGCCAAAGATGAGTCTCCCG- 3´ 
Ep 6rStop 5´- CTGGTCTCGAGTCACCAAAGATGAGTCTC – 3´ 
 
Note: DRP1 primer Ep 6r was used for constructs E 65 and E 67 – E 68 that were 
cloned into the vector pET-21. DRP1 primer Ep 6rStop was used for construct E 64 
that was cloned into the vector pHIS-Parallel2. 
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DRP1 fusion/mutation primers: 
E 64:  
Ep 26f 
Ep 26r 
 
5´-GGTGAACCCGTGGATGGATCAGGATCAGGATCAGGATCA -3´ 
5´-ATCAGCTGCTTCTTTTGATCCTGATCCTGATCCTGATCC – 3´ 
E 65: 
Ep 27f 
Ep 27r 
 
5´-GGTGAACCCGTGGATGGATCAGGATCAGGATCAGGATCA -3´ 
5´- CCGAGCAGATAGTTTTGATCCTGATCCTGATCCTGATCC – 3´ 
E 67: 
Ep 28f 
Ep 28r 
 
5´- GACATTTTGACTGACATTAGAAATGC -3´ 
5´- GCATTTCTAATGTCAGTCAAAATGTC -3´ 
E 68: 
Ep 29f 
Ep 29r 
 
5´- GTAACACTATTGAAGATACTGCAAAATATATTG -3´ 
5´- CAATATATTTTGCAGTATCTTCAATAGTGTTAC -3´ 
E 69: 
Ep 30f 
Ep 30r 
 
5´- GAGCTATGCGGTGATGCTAGAATTTG -3´ 
5´- CAAATTCTAGCATCACCGCATAGCTC -3´ 
 
Primers flanking MCS of pET-21 and pHIS-Parallel2: 
T7f 5´- TAA TAC GAC TCA CTA TAG GG – 3´ 
T7r 5´- CTA GTT ATT GCT CAG CGG T – 3´ 
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2.2. MARKERS 
DNA GEL ELECTROPHORESIS     SDS- POLYACRYLAMIDE GEL ELECTROPHORESIS 
 
 1 kb DNA Ladder *    Prestained Protein Ladder* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Both markers were obtained from Fermentas Life Sciences. 
    
2.3. RESTRICTION SITES OF NDEI AND XHOI 
NdeI:     and XhoI: 
55...C A5T A T G...35       55...C5T C G A G...35 
35...G T A T5A C...55   35...G A G C T5C...55 
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3. BUFFERS, REAGENTS AND ENZYMES 
3.1. CLONING 
3.1.1. ENZYMES 
iProof High-Fidelity Polymerase (Bio-Rad)   0,04 u/µL 
Fast digest restriction enzyme NdeI     1 u/µL 
Fast digest restriction enzyme XhoI    1 u/µL 
FastAP Thermosensitive Alkaline Phosphatase   1 u/µL 
T4 DNA Ligase       5 u/µL 
DreamTaq Green DNA Polymerase    5 u/µL 
RNase-free DNase I       1 u/µL    
Unless otherwise stated, enzymes were obtained from Fermentas Life Sciences. 
 
3.1.2. AGAROSE GEL ELECTROPHORSIS 
1% Agarose Gel  1 g Agarose 
    100 mL 1 x TAE 
 
50 x TAE Buffer  2 M Tris    242 g Tris 
    5,7 % (v/v) Acetic acid  57,1 mL Acetic acid 
    64 mM EDTA   18,6 g EDTA 
    dd H₂O up to 1 L     
 
10 x DNA Loading   2 mL 50 x TAE 
Dye    30% Glycerol 
    trace of Bromphenolblue 
 
60 x GelRed   GelRed nucleic acid stain (Biotium Inc.) 10 000x 
    3 µL GelRed to 497 µL dd H2O 
    final concentration: 3 x 
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3.2. PROTEIN EXPRESSION 
Ampicillin   final concentration: 50 µg/mL 
    50 mg/mL stock: 500 mg in 10 mL dd H₂O 
 
IPTG    Isopropyl-ß-D-thiogalactopyranosid   
    final concentration: 0,42 mM    
    0,42 M stock: 1 g to 10 mL dd H₂O 
 
PMSF    Phenylmethylsulfonylfluoride    
    final concentration: 1 mM     
    200 mM stock: 70 mg in 2 mL 96% Ethanol 
 
Lysis Buffer   50 mM KH₂PO₄   6,8 g KH₂PO₄ 
pH 7.8             300 mM NaCl   60 mL 5 M NaCl 
0,1 mg/mL Lysozyme  0,1 g Lysozyme 
10 % Glycerol   100 mL Glycerol 
dd H₂O up to 1 L    
 
 
 
 
 
 
 
 
 
 
 
3.3. SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS 
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SDS-Polyacrylamide Gel   15 % Resolving gel  4 % Stacking gel 
   1.5 M Tris pH 8.8  18 mL    - 
   0.5 M Tris pH 6.8  -    9 mL 
   20 % SDS   360 µL   180 µL 
   40 % Acrylamide  27 mL    3.6 mL 
   dd H₂O   22.9 mL   23.5 mL 
   10 % APS   504 µL   270 µL 
   TEMED   54.4 µL   27.2 µL 
          + Bromphenolblue 
 
SDS-Running Buffer 383 mM Glycine   28,8 g Glycine  
pH 8.3   50 mM Tris    6 g Tris  
    0,1 % SDS    1 g SDS 
    dd H₂O up to 1 L    
 
10 x SDS Loading  60 mM Tris     600 µL 1 M Tris 
Buffer  pH 6.8  0,1 M DTT    0,15 g DTT 
    5 % SDS    0,5 g SDS 
    10 % Glycerol   1 mL Glycerol 
    trace of Bromphenolblue 
 
Staining Solution  50 % Ethanol    500 mL Ethanol 
    10 % Acetic acid    100 mL Acetic acid 
    0,1 % Coomassie Brilliant Blue  1 g Coomassie B.B. 
dd H₂O up to 1 L 
 
Destaining Solution  25 % Ethanol   250 mL Ethanol 
    10 % Acetic acid   100 mL Acetic acid 
dd H₂O up to 1 L 
 
3.4. PROTEIN PURIFICATION 
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3.4.1. IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY 
Equilibration buffer  20 mM Tris    20 mL 1 M Tris 
pH 7.8   300 mM NaCl   60 mL 5 M NaCl 
    10 % Glycerol   100 mL Glycerol 
    10 mM Imidazole   10 mL 1 M Imidazole 
 dd H₂O up to 1 L    
 
Wash Buffer   20 mM Tris    20 mL 1 M Tris  
pH 7.8   300 mM NaCl   60 mL 5 M NaCl 
    10 % Glycerol   100 mL Glycerol 
    40 mM Imidazole   40 mL 1 M Imidazole 
    10 % Sucrose   100 g Sucrose 
 dd H₂O up to 1 L    
 
Elution Buffer  25 mM Tris    25 mL Tris 
pH 7.8   300 mM NaCl   60 mL 5 M NaCl 
    500 mM Imidazole   500 mL 1 M Imidazole 
    15 % Glycerol   150 mL Glycerol 
dd H₂O up to 1 L    
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3.4.2. SIZE EXCLUSION CHROMATOGRAPHY 
SEC Buffer   30 mM Tris    30 mL 1 M Tris 
pH 7.8   100 mM NaCl   20 mL 5 M NaCl 
    1 mM EDTA    2 mL 0,5 M EDTA 
    2 mM DTT    0,308 g DTT 
dd H₂O up to 1 L    
    sterile filtered and degassed 
 
 
SEC Buffer 2  30 mM Tris    30 mL 1 M Tris 
pH 7.8   150 mM NaCl   30 mL 5 M NaCl 
    4 mM MgCl₂    4 mL 1 M MgCl₂  
dd H₂O up to 1 L    
    sterile filtered and degassed 
 
SEC Buffer 3  20 mM Tris    20 mL 1 M Tris 
pH 8    150 mM NaCl   30 mL 5 M NaCl 
    2 mM EGTA    760 g EGTA 
    4 mM MgCl₂    4 mL 1 M MgCl₂ 
    1 mM DTT    154 mg DTT 
dd H₂O up to 1 L    
    sterile filtered and degassed 
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3.5. THERMOFLUOR ASSAY 
List of buffers tested in Thermofluor assay: 
 
 
 
3.6. GTPASE ASSAY 
GTPase Assay  150 mM NaCl   30 mL 5 M NaCl 
Buffer  pH 7   25 mM HEPES   50 mL 0,5 M HEPES 
    25 mM PIPES   50 mL 0,5 M PIPES 
dd H₂O up to 1 L   
 
20 x Reaction Buffer  25 mM HEPES    50 mL 0,5 M HEPES 
pH 7    25 mM PIPES   50 mL 0,5 M PIPES 
100 mM MgCl2   100 mL 1 M MgCl₂ 
20 mM PEP    3,36 g PEP 
150 mM KCl    30 mL 5 M KCl 
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3.7. MISCELLANEOUS 
 
100 mM GDP  guanosine 5´-diphosphate sodium salt* 
    Mr = 443,2 g/mol 
    44.32 mg per 1 mL ddH₂O 
    adjust pH to 7 with 0,5 M NaOH 
 
100 mM GTP  guanosine 5`-triphosphate sodium salt hydrate*  
    Mr = 523,18 g/mol 
    52.32 mg per 1 mL ddH₂O 
    adjust pH to 7 with 0,5 M NaOH 
 
100 mM GMP-PCP guanosine 5`-[beta,gamma-imido]triphosphate sodium salt 
hydrate* 
    Mr = 529,93 g/mol 
    52.99 mg per 1 mL ddH₂O 
    adjust pH to 7 with 0,5 M NaOH 
*obtained from Sigma-Aldrich Life Sciences 
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